当前位置:首页 - 行情中心 - 益方生物-U(688382) - 财务分析

益方生物-U

(688382)

  

流通市值:38.67亿  总市值:56.28亿
流通股本:3.96亿   总股本:5.77亿

益方生物-U(688382)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.83亿元,每股收益-0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益193463.63万元,未分配利润-238789.95万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产207676.95万元,负债14213.33万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入8,606,045.1185,526,866.85127,169,811.3280,000,000
营业总成本91,335,787.52469,863,109.82372,732,029.87250,395,350.48
营业利润-83,177,667.08-283,975,274.61-241,261,887.25-167,749,388.63
利润总额-83,177,667.08-283,975,274.61-241,261,887.25-167,749,388.63
净利润-83,177,667.08-283,975,274.61-241,261,887.25-167,749,388.63
其他综合收益-593,516.15-337,857.53-592,304.62-102,798.81
综合收益总额-83,771,183.23-284,313,132.14-241,854,191.87-167,852,187.44
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,039,818,127.182,123,120,943.272,113,515,925.862,129,648,894.43
非流动资产合计36,951,398.9139,151,100.0744,682,661.574,155,768.83
资产总计2,076,769,526.092,162,272,043.342,158,198,587.362,203,804,663.26
流动负债合计136,107,950.34158,274,268.42126,541,209.6113,932,770.83
非流动负债合计6,025,304.116,395,255.158,625,707.8510,655,855.83
负债合计142,133,254.45164,669,523.57135,166,917.45124,588,626.66
归属于母公司股东权益合计1,934,636,271.641,997,602,519.772,023,031,669.912,079,216,036.6
股东权益合计1,934,636,271.641,997,602,519.772,023,031,669.912,079,216,036.6
负债和股东权益合计2,076,769,526.092,162,272,043.342,158,198,587.362,203,804,663.26
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计5,819,313.65111,499,363.7890,660,912.618,979,099.84
经营活动现金流出小计95,539,960.93419,251,528.17325,261,146.62211,785,881.24
经营活动产生的现金流量净额-89,720,647.28-307,752,164.39-234,600,234.01-202,806,781.41
投资活动现金流入小计-506,953,474.39506,953,474.39-
投资活动现金流出小计847,764.151,206,285,912.07505,034,442.11503,438,567.76
投资活动产生的现金流量净额-847,764.15-699,332,437.681,919,032.28-503,438,567.76
筹资活动现金流入小计7,215,958.3516,293,307.916,293,307.9-
筹资活动现金流出小计2,481,093.7629,859,061.7625,952,261.286,965,061.79
筹资活动产生的现金流量净额4,734,864.59-13,565,753.86-9,658,953.38-6,965,061.79
汇率变动对现金及现金等价物的影响-365,816.871,265,109.662,857,342.444,455,925
现金及现金等价物净增加额-86,199,363.71-1,019,385,246.27-239,482,812.67-708,754,485.96
期末现金及现金等价物余额1,129,626,308.861,215,825,672.571,995,728,106.171,526,456,432.88
最新报告期:2024-02-20
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
光大证券张瀚予-0.32-0.08--2024-02-20
TOP↑